期刊文献+

siRNA沉默MIF基因抑制骨肉瘤143B细胞增殖

Inhibiting the proliferation of osteosarcoma 143B cell by blocking the MIF gene with siRNA
下载PDF
导出
摘要 背景:巨噬细胞移动抑制因子(MIF)是一种多功能细胞因子,其在人体炎症、免疫反应和肿瘤发生发展中起重要作用。目的:研究应用小干扰RNA(siRNA)干扰RNA(RNAi)技术阻断MIF基因表达后对骨肉瘤细胞株143B细胞增殖的抑制效应。方法:转染MIF-siRNA为实验组,转染Fam-siRNA为对照组,采用免疫荧光法观测siRNA的转染率,分别用q-PCR和Western blot检测143B细胞中MIF-mRNA和MIF蛋白的表达水平,用MTT法检测143B细胞增殖能力。结果:实验组MIF-mRNA基因的相对表达量为对照组的26%,相比较有统计学差异(P<0.05);实验组MIF蛋白的相对表达量约为对照组的30%,相比较有统计学差异(P<0.05);143B细胞转染72h后,实验组能显著抑制143B细胞的活性。结论:MIF在骨肉瘤的发生发展过程中发挥重要作用,MIF-siRNA能阻断MIF蛋白表达,从而抑制143B细胞增殖,提示其可能成为骨肉瘤的新治疗靶点。 Background:Macrophage migration inhibitory factor(MIF) is a kind of pluripotent cytokine that plays an important role in human inflammation,immune responses,and tumor genesis and development.Objective:Adopting the small interfering RNA(siRNA) RNA interference(RNAi) technique to block the gene expression of MIF,and investigate its inhibitory effect on the proliferation of osteosarcoma cell line 143B cell.Methods:Take the MIF-siRNAtransfection group as the experimental group,and the Fam-siRNAtransfection group as the comparison group;observe the transfection efficiency by immunofluorescence technique;detect the expression level of MIF-mRNA and MIF protein in 143B cell by q-PCR and Western blot technique;and test the proliferation ability of 143B cell by MTT assay.Results:The relative gene expression quantity of MIF-mRNA in the experimental group was 26% higher than in the comparison group,there were statistical differences between the two groups(P0.05);and the relative gene expression quantity of MIF protein in the experimental group was 30% higher than in the comparison group,there also existed statistical differences(P0.05).72 hours later after the transfection,the viability of the 143B cells were significantly inhibited in the experimental group.Conclusions:MIF plays an important role in the genesis and development of osteosarcoma;the MIF-siRNA can block the expression of the MIF protein and consequently inhibit the proliferation of 143B cells,thus it can be a new therapeutic target for osteosarcoma.
出处 《中国骨与关节外科》 2013年第3期270-273,共4页 Chinese Journal of Bone and Joint Surgery
基金 江苏省自然科学基金(BK2010461)
关键词 巨噬细胞移动抑制因子(MIF) 小干扰RNA(siRNA) 骨肉瘤 macrophage migration inhibitory factor(MIF) small interfering RNA(siRNA) Osteosarcoma
  • 相关文献

参考文献15

  • 1吴苏稼,施鑫,周光新,陆萌,黎承军,王蔚雯,赵建宁.新辅助化疗加保肢治疗四肢成骨肉瘤[J].江苏医药,2010,36(2):163-166. 被引量:12
  • 2Cooke G, Armstrong ME, Donnelly SC. Macrophage migra- tion inhibitory factor(M/F), enzymatic activity and the in- flammatory response. Biofactors, 2009, 35(2): 165-168.
  • 3Link MP, Goorin AM, Miser AW, et al. The effect of adju- vant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med, 2005, 314 (25): 1600-1606.
  • 4Calandra T, Roger T. Macrophage migration inhibitory fac- tor: a regulator of innate immunity. Nat Rev Immunol, 2003, 3(10): 791-800.
  • 5Simons D, Grieb G, Hristov M, et al. Hypoxia-induced endo- thelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med, 2011, 15(3): 668-678.
  • 6方刚,赵建宁,陶亮.siRNA抑制小鼠腹腔巨噬细胞分泌肿瘤坏死因子-α的实验研究[J].医学研究生学报,2011,24(3):333-334. 被引量:7
  • 7Mitchell RA. Mechanisms and effectors of MIF dependent promotion oftumourigenesis. Cell Signal, 2004, 16(1): 13-19.
  • 8Conroy H, Mawhinney L, Donnelly SC. Inflammation and cancer: macrophage migration inhibitory factor (MIF)-thepotential missing link. QJM, 2010, 103(11): 831-836.
  • 9Chesney J, Metz C, Baeher M, et al. An essential role for macrophage migration inhibitory factor (MIF) in angiogene- sis and the growth of a murine lymphoma. Molecular Medi- cine, 1999, 5(3): 181-191.
  • 10Mitchell RA. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cel Signal, 2004, 16(1): 13-19.

二级参考文献60

  • 1熊进,蒋青,骆东山,宋知非,朱丽华,王斌,陈晖.应用人工关节置换治疗骨肿瘤[J].江苏医药,2004,30(8):611-612. 被引量:4
  • 2方刚,XUE Cheng-yuan,韩晓冬.小分子干扰RNA片段逆转KBv200细胞多药耐药的实验研究[J].医学研究生学报,2006,19(2):104-106. 被引量:7
  • 3CALANDRA T,BERNHAGEN J,METZ CN,et al.MIF as a glucocorticoid-induced modulator of cytokine production[J].Nature,1995,377(6544):68-71.
  • 4DAS UN.Current advances in sepsis and septic shock with particular emphasis on the role of insulin[J].Med Sci Monit,2003,9(8):RA181-192.
  • 5LUE H,KLEEMANN R,CALANDRA T,et al.Macrophage migration inhibitory factor (MIF):mechanisms of action and role in disease[J].Microbes Infect,2002,4(4):449-460.
  • 6MCLEAN GW,AVIZIENYTE E,FRAME MC.Focal adhesion kinase as a potential target in oncology[J].Expert Opin Pharmacother,2003,4(2):227-234.
  • 7ANDERSON SI,SHINER R,BROWN MD,et al.ICAM-1 expression and leukocyte behavior in the microcirculation of chronically ischemic rat skeletal muscles[J].Microvasc Res,2006,71(3):205-211.
  • 8WITKOWSKA AM.Soluble ICAM-1:a marker of vascular inflammation and lifestyle[J].Cytokine,2005,31(2):127-134.
  • 9MILLS PJ,PARKER B,JONES V,et al.The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer[J].Clin Cancer Res,2004,10(15):4998-5003.
  • 10MARKOWSKA A,URASINSKA E,DOMAGALA W.In vitro assessment of adhesion molecules expression by human endothelial cells cocultured with c-erbB2-positive and c-erbB2-negative breast carcinoma cell lines[J].Pol J Pathol,2008,59 (1):49-54.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部